These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32745221)

  • 21. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review.
    Tsukamoto S; Tanaka Y; Mavrogenis AF; Kido A; Kawaguchi M; Errani C
    Clin Orthop Relat Res; 2020 May; 478(5):1076-1085. PubMed ID: 31794487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
    Chawla S; Blay JY; Rutkowski P; Le Cesne A; Reichardt P; Gelderblom H; Grimer RJ; Choy E; Skubitz K; Seeger L; Schuetze SM; Henshaw R; Dai T; Jandial D; Palmerini E
    Lancet Oncol; 2019 Dec; 20(12):1719-1729. PubMed ID: 31704134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A; Gulia A; Hegde P; Verma V; Rekhi B
    Bone Joint J; 2019 Feb; 101-B(2):170-177. PubMed ID: 30700112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab.
    Chinder PS; Hindiskere S; Doddarangappa S; Pal U
    Clin Orthop Surg; 2019 Sep; 11(3):352-360. PubMed ID: 31475058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ASO Author Reflections: Preoperative Denosumab May Increase the Risk of Local Recurrence of Giant Cell Tumor of Bone after Curettage Surgery.
    Asano N; Horiuchi K
    Ann Surg Oncol; 2022 Jun; 29(6):4001. PubMed ID: 35169975
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.
    Urakawa H; Mizusawa J; Tanaka K; Eba J; Hiraga H; Kawai A; Nishida Y; Hosaka M; Iwamoto Y; Fukuda H; Ozaki T
    Jpn J Clin Oncol; 2019 Apr; 49(4):379-382. PubMed ID: 30796832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of intraoperative magnetic resonance imaging for giant cell tumor of bone after denosumab treatment: a pilot study.
    Furuta T; Kubo T; Sakuda T; Saito T; Kurisu K; Muragaki Y; Adachi N
    Acta Radiol; 2022 Feb; 63(2):176-181. PubMed ID: 33517664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
    Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
    Palmerini E; Seeger LL; Gambarotti M; Righi A; Reichardt P; Bukata S; Blay JY; Dai T; Jandial D; Picci P
    BMC Cancer; 2021 Jan; 21(1):89. PubMed ID: 33482769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L; Dijkstra S; van de Sande M; Gelderblom H
    Curr Opin Oncol; 2020 Jul; 32(4):332-338. PubMed ID: 32541321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Giant cell tumour of bone in the denosumab era.
    van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
    Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.
    Rutkowski P; Gaston L; Borkowska A; Stacchiotti S; Gelderblom H; Baldi GG; Palmerini E; Casali P; Gronchi A; Parry M; Campanacci DA; Scoccianti G; Wagrodzki M; Ferrari S; Dijkstra S; Pieńkowski A; Grimer R
    Eur J Surg Oncol; 2018 Sep; 44(9):1384-1390. PubMed ID: 29650420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical challenges, novel techniques, and systemic treatment of giant cell tumour of bone of the distal radius : clinical outcomes and systematic review of the literature.
    van der Heijden L; Bindt S; Scorianz M; Ng C; Gibbons MCLH; van de Sande MAJ; Campanacci DA
    Bone Jt Open; 2022 Jul; 3(7):515-528. PubMed ID: 35775196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E; Chawla NS; Ferrari S; Sudan M; Picci P; Marchesi E; Leopardi MP; Syed I; Sankhala KK; Parthasarathy P; Mendanha WE; Pierini M; Paioli A; Chawla SP
    Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Wrist Arthrodesis With Structural Iliac Crest Bone Graft After Wide Resection of Distal Radius Giant Cell Tumor Result in Satisfactory Function and Local Control?
    Wang T; Chan CM; Yu F; Li Y; Niu X
    Clin Orthop Relat Res; 2017 Mar; 475(3):767-775. PubMed ID: 26728519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Denosumab does not decrease the risk of lung metastases from bone giant cell tumour.
    Tsukamoto S; Mavrogenis AF; Leone G; Righi A; Akahane M; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
    Int Orthop; 2019 Feb; 43(2):483-489. PubMed ID: 30099641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional outcome in giant cell tumor of distal radius treated with excision and fibular arthroplasty: a case series.
    Barik S; Jain A; Ahmad S; Singh V
    Eur J Orthop Surg Traumatol; 2020 Aug; 30(6):1109-1117. PubMed ID: 32358713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of denosumab in the setting of acute pathological fracture through giant cell tumour of bone.
    Weschenfelder W; Abrahams JM; Johnson LJ
    World J Surg Oncol; 2021 Feb; 19(1):37. PubMed ID: 33530997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant cell tumour of bone.
    Aoude A; Nikomarov D; Perera JR; Ibe IK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS
    Bone Joint J; 2023 May; 105-B(5):559-567. PubMed ID: 37121582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.